论文部分内容阅读
目的:为药学科研工作者提供“含有抗原或抗体的医药配制品”(A61K39)疫苗类发明专利的相关信息,并为药品研发提供参考。方法:通过国家知识产权局专利信息服务平台试验系统,采用国际专利分类法(IPC)对1985-2010年在我国申请的、主分类号为A61K39的专利进行检索,并将其按申请年份、申请国别及IPC小组分类进行统计、分析。结果与结论:共检索到发明专利2776件;1985-1992年的年申请数量均在15件以内,1993-2006年由32件上升至350件,2007-2010年由294件下降至20件;申请国别以美国最多(883件),我国省(区、市)以北京最多(178件);由IPC小组分类的A61K39/395(含有抗体、免疫球蛋白、免疫血清的医药配制品)的申请数量最多,共820件,说明含有抗体、免疫球蛋白、免疫血清的医药配制品是目前的研发热点。
OBJECTIVE: To provide pharmacy researchers with relevant information on the invention patent of “vaccine containing antigen or antibody” (A61K39) vaccine and to provide a reference for drug research and development. Methods: Through the patent information service platform test system of State Intellectual Property Office, the International Patent Classification (IPC) was used to search the patent application A61K39 in China from 1985 to 2010 and apply it according to the application year Country and IPC group classification for statistics, analysis. RESULTS AND CONCLUSION: A total of 2,776 invention patents were retrieved; the number of annual applications in 1985-1992 was within 15 cases, from 32 to 350 cases in 1993-2006, and from 294 to 20 cases in 2007-2010; The largest number of applicants in the United States (883 cases) and the most provinces (autonomous regions and municipalities) in China were Beijing (178 cases); A61K39 / 395 (pharmaceutical preparations containing antibodies, immunoglobulins and immune sera) classified by the IPC group The largest number of applications, a total of 820, indicating that containing antibodies, immunoglobulins, immune serum pharmaceutical preparations is the current research and development hot spots.